Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.250
-0.050 (-3.85%)
At close: Mar 28, 2025, 4:00 PM
1.240
-0.010 (-0.80%)
Pre-market: Mar 31, 2025, 9:27 AM EDT

Editas Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-237.09-153.22-220.43-192.5-115.98
Upgrade
Depreciation & Amortization
5.816.066.345.053.96
Upgrade
Loss (Gain) From Sale of Assets
0.15----
Upgrade
Asset Writedown & Restructuring Costs
----27.5
Upgrade
Loss (Gain) From Sale of Investments
-5.79-4.82-0.721.66-16.37
Upgrade
Stock-Based Compensation
21.4219.829.2943.423.16
Upgrade
Other Operating Activities
1.781.6--0.1
Upgrade
Change in Accounts Receivable
-6.08-5.04-4.885.78-5.63
Upgrade
Change in Accounts Payable
-2.29-1.494.37-1.140.86
Upgrade
Change in Unearned Revenue
-8.46--3.33-22.71-91.79
Upgrade
Change in Other Net Operating Assets
20.284.9412.02-3.35-5.65
Upgrade
Operating Cash Flow
-210.28-132.18-177.35-163.8-179.84
Upgrade
Capital Expenditures
-8.83-4.72-4.12-7.98-7.16
Upgrade
Sale of Property, Plant & Equipment
--0.02-0.01
Upgrade
Investment in Securities
170.970.99118.17-46.49-133.37
Upgrade
Investing Cash Flow
162.15-3.73114.07-54.47-140.52
Upgrade
Issuance of Common Stock
0.78118.041.28282.11224.12
Upgrade
Other Financing Activities
55.24----
Upgrade
Financing Cash Flow
56.03118.041.28282.11224.12
Upgrade
Net Cash Flow
7.89-17.87-6263.84-96.24
Upgrade
Free Cash Flow
-219.11-136.9-181.47-171.78-187.01
Upgrade
Free Cash Flow Margin
-678.06%-175.23%-920.59%-672.49%-206.11%
Upgrade
Free Cash Flow Per Share
-2.66-1.80-2.64-2.54-3.19
Upgrade
Levered Free Cash Flow
-121.09-87.81-102.27-85.55-77.36
Upgrade
Unlevered Free Cash Flow
-121.09-87.81-102.27-85.55-77.36
Upgrade
Change in Net Working Capital
-9.843.21-7.445.3113.04
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q